Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence

Ridge, Gayle; Gossop, Michael; Lintzeris, Nicholas; Witton, John; Strang, John

doi:10.1016/j.jsat.2008.09.007

Cited by 42 publications

(30 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, physicians identified the need for greater organizational and peer support to facilitate their delivery of quality treatment. The importance of such support mechanisms has been identified as a key factor in the implementation of evidence-based guidelines into practice [29][30][31] .…”

Section: Discussionmentioning

confidence: 99%

“…These findings suggest that improved support and organizational assistance for physicians is necessary to attract greater involvement in OST. This conclusion is echoed in studies from the UK and USA, where physicians report that improved access to training (including continuing medical education credits), the ability to refer difficult patients back to specialized clinics, and consultant support [8,9,28,31,32] would most likely increase OST provision.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians

Stöver¹

2010

Eur Addict Res

View full text Add to dashboard Cite

Background/Aims: Although the number of patients in opioid substitution treatment (OST) in Germany has increased in recent years, many dependent opioid users remain out of treatment. Project IMPROVE assessed attitudes and beliefs regarding barriers to OST. Methods: Data were collected from opioid-dependent individuals (using self-complete questionnaires) currently in treatment (n = 200) or not in treatment (n = 200), and OST-accredited physicians (using computer-aided telephone interviewing) who currently provided (n = 101) or did not provide OST (n = 51) from different regions in Germany. Results: Key results showed that OST was perceived as valuable and effective by physicians, patients and users but that OST access and provision were inadequate, especially outside of major cities. Conclusion: These findings are consistent with national data indicating a worsening imbalance between patient demand for treatment and the supply of available physicians accredited to provide it. Many physicians and patients were not aware of, or were not utilizing, therapeutic strategies that may help reduce misuse and diversion. Improvements in the regulatory framework for OST, and identifying additional sources of support and training, would encourage more accredited physicians to actively provide treatment and thus help to fully realize the benefits of currently available treatment options.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians

Stöver¹

2010

Eur Addict Res

View full text Add to dashboard Cite

show abstract

“…A survey conducted in London, UK, similarly found that patient preference influenced providers' prescribing decisions, with patients preferring methadone over buprenorphine treatment having higher odds of receiving their preferred medication (and vice versa) (Ridge et al, 2009). …”

Section: Patient Views Of Opioid Pharmacotherapy Bio-delivery Systemsmentioning

confidence: 99%

“…Questionnaire (SATMED-Q) (Ruiz et al, 2008). SATMED-Q is a generic instrument, with good psychometric properties, designed for use with patients undergoing pharmacological treatment for any chronic disease.…”

Section: Our Findings Show Notable Overlap With the Treatment Satisfamentioning

confidence: 99%

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Neale

Tompkins

Strang

2018

Experimental and Clinical Psychopharmacology

Self Cite

View full text Add to dashboard Cite

The technology for delivering opioid pharmacotherapy (OPT) is expanding. It is important to know what OPT patients think of these developments, and to find ways of enabling patients and clinicians to make informed decisions about which bio-delivery system to choose. We explored the views of current and former OPT patients with a history of heroin use to identify factors influencing their preferences regarding routes of OPT administration. Data were generated via seven focus groups conducted in London, United Kingdom. Participants (n=44) considered standard bio-delivery systems (liquid/linctus, tablet, injectables), emergent systems (implants, depot injections), and a hypothetical system (nasal sprays). Groups were audio-recorded, transcribed verbatim, coded using qualitative software, and analyzed inductively via Iterative Categorization. Participants were cautious of, but willing to consider, new ways of receiving OPT and they welcomed having more choice. Their preferences and decision-making processes were influenced by nine interconnected factors: 1. personal dislike of particular bio-delivery systems; 2. desired feelings following OPT administration; 3.perceived effectiveness of OPT bio-delivery systems; 4. concerns about side effects; 5. ability to control the OPT; 6. impact on daily lives; 7. concerns about OPT-related stigma; 8. need for psychosocial support; and 9. personal treatment goals. This complexity may make it difficult for patients and clinicians to evaluate the pros and cons of the expanding array of OPT bio-delivery systems and to arrive at clear conclusions. We therefore use the findings to Article accepted by Experimental and Clinical Psychopharmacology 3 construct a checklist that may facilitate discussions with patients when decisions about OPT need to be made. KEYWORDS

show abstract

“…Further, it is unclear whether results from existing studies are generalizable to the population of patients treated in office-based settings, revealing a possible knowledge gap for addiction treatment providers and researchers. This gap in knowledge presents an opportunity to examine and document clinical process and treatment outcomes associated with the office-based approach to opioid replacement therapy to better understand patient characteristics (e.g., demographics, biopsychosocial functioning, and treatment history), treatment response, service demands, and provider practice patterns (Ridge, Gossop, Lintzeris, Witton, & Strang, 2009). However, access to and identification of these patients for enrollment in SAT studies are challenges for the field and will likely require innovative approaches for participant recruitment, enrollment, data collection, and study retention.…”

Section: Introductionmentioning

confidence: 99%

A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: Study feasibility and sample description

Ruetsch¹,

Cacciola

Tkacz³

2010

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence

Cited by 42 publications

References 23 publications

Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians

Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: Study feasibility and sample description

Contact Info

Product

Resources

About